- Daiichi Sankyo, Inc. (Bernards, NJ)
- …with the brand team, HEOR (Health Economics and Outcomes Research ), RD ( Research Development), FMA (Field Medical Affairs), MIE ( Medical Information and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...Research (ESRs) and may serve as deputy regional medical lead in Global IIS Review Committee meetings. May… more
- Novo Nordisk Inc. (Hackensack, NJ)
- …class therapies for the treatment of diabetes, obesity, and the reduction of adverse cardiovascular events. As part of the team, you will have frontline exposure to ... (eg, DBMs, IDBMs, DCSs, IDCSs, Managed Markets Sales Team, Diabetes Educators, Medical Liaisons) covering the same geographic areas. The EDCS actively shares… more
- Merck & Co. (Rahway, NJ)
- …Global Regulatory Affairs and Clinical Safety (GRACS) function of Our Company's Research Laboratories ( Research & Development) by:Developing an active engagement ... innovative and accelerated regulatory strategy and marketing authorizations for Cardiovascular , Diabetes, Respiratory, Immunology, Neuroscience, Ophthalmology and Women's Health… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …License Partners, Reconciliation with License Partners, Patient Support Programs, Market Research vendors, Global Quality Supply Chain, Medical Information ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …execution plans across and effective alignment within (eg with translational research , clinical operations, clinical development, medical affairs CSPV and ... to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class...In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Novo Nordisk Inc. (Boston, MA)
- …class therapies for the treatment of diabetes, obesity, and the reduction of adverse cardiovascular events. As part of the team, you will have frontline exposure to ... prescribing within the health system context, utilizing tailored strategies and research -based account plans Represent Novo Nordisk at academic institutions to… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (New York, NY)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.… more
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and ... In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group's 2025 Vision to become...providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disordersJob… more
